Health Technology · Pharmaceuticals: Major · NSE: ONESOURCE · data 2026-10-09
OneSource Specialty Pharma Limited
Health check: Weak (3.2/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,461.3
Market cap
₹16,942 cr
P/E
—
P/B
—
ROE
-1.3%
ROCE
-0.1%
Debt / equity
0.26
Dividend yield
0.00%
1-year return
-22.0%
52-week high
₹1,925
52-week low
₹1,057
Operating margin
3.6%
Growth
| Revenue (last 12 months) | ₹1,543 cr |
| Net profit (last 12 months) | ₹-49 cr |
| Sales growth, 3 years (yearly) | 232.4% |
| Profit growth, 3 years (yearly) | — |
Similar companies
PFIZER LIMITED (PFIZER) · Cohance Lifesciences Ltd (COHANCE) · Alivus Life Sciences Ltd (ALIVUS) · Eris Lifesciences Ltd (ERIS) · Alembic Pharmaceuticals Limited (APLLTD)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ONESOURCE in NSE Scanner →